Log in to save to my catalogue

Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory...

Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2490317831

Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study

About this item

Full title

Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study

Publisher

United States: Public Library of Science

Journal title

PLoS medicine, 2020-12, Vol.17 (12), p.e1003432

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Glucocorticoids are widely used to reduce disease activity and inflammation in patients with a range of immune-mediated inflammatory diseases. It is uncertain whether or not low to moderate glucocorticoid dose increases cardiovascular risk. We aimed to quantify glucocorticoid dose-dependent cardiovascular risk in people with 6 immune-mediated infla...

Alternative Titles

Full title

Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2490317831

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2490317831

Other Identifiers

ISSN

1549-1676,1549-1277

E-ISSN

1549-1676

DOI

10.1371/journal.pmed.1003432

How to access this item